Literature DB >> 17259589

Miniaturized receptor binding assays: complications arising from ligand depletion.

Clare M Scaramellini Carter1, Juliet R Leighton-Davies, Steven J Charlton.   

Abstract

The advent of miniaturized assay formats has made possible the screening of large numbers of compounds against a single target, known as high-throughput screening. Despite this clear advantage, assay miniaturization also increases the risk of ligand depletion, where the actual concentration of free ligand is significantly lower than that added. This, in turn, complicates the interpretation of data from such assays, potentially introducing significant error if not recognized. In this study, the effects of reducing assay volume on radioligand Kd and competitor Ki values have been investigated, using the muscarinic M(3) receptor as a model system. It was found that assay miniaturization caused dramatic effects, with up to a 30-fold underestimation of ligand affinity. A theoretical model was developed and shown to accurately predict both the degree of ligand depletion in any given assay volume and the effect of this depletion on affinity estimates for competing ligands. Importantly, it was found that in most cases, errors introduced by ligand depletion could be largely corrected for by the use of appropriate analysis methods. In addition to those previously described by others, the authors propose a simple method capable of correcting errors in competition binding experiments performed in conditions of ligand depletion.

Mesh:

Substances:

Year:  2007        PMID: 17259589     DOI: 10.1177/1087057106297788

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  13 in total

1.  Simulating the influence of plasma protein on measured receptor affinity in biochemical assays reveals the utility of Schild analysis for estimating compound affinity for plasma proteins.

Authors:  D Blakeley; D A Sykes; P Ensor; E Bertran; P J Aston; S J Charlton
Journal:  Br J Pharmacol       Date:  2015-10-22       Impact factor: 8.739

2.  Slow receptor dissociation is not a key factor in the duration of action of inhaled long-acting β2-adrenoceptor agonists.

Authors:  David A Sykes; Steven J Charlton
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 3.  Ligand binding assays at equilibrium: validation and interpretation.

Authors:  Edward C Hulme; Mike A Trevethick
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

4.  Synthesis and characterization of [³H]-SN56, a novel radioligand for the σ₁ receptor.

Authors:  James A Fishback; Christophe Mesangeau; Jacques H Poupaert; Christopher R McCurdy; Rae R Matsumoto
Journal:  Eur J Pharmacol       Date:  2010-12-02       Impact factor: 4.432

5.  Exploring the kinetic selectivity of drugs targeting the β1 -adrenoceptor.

Authors:  David A Sykes; Mireia Jiménez-Rosés; John Reilly; Robin A Fairhurst; Steven J Charlton; Dmitry B Veprintsev
Journal:  Pharmacol Res Perspect       Date:  2022-08

6.  Reassessment of the pharmacology of Sphingosine-1-phosphate S1P3 receptor ligands using the DiscoveRx PathHunter™ and Ca2+ release functional assays.

Authors:  D M Riddy; C Stamp; D A Sykes; S J Charlton; M R Dowling
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

7.  Characterizing low affinity epibatidine binding to α4β2 nicotinic acetylcholine receptors with ligand depletion and nonspecific binding.

Authors:  Alexandra M Person; Gregg B Wells
Journal:  BMC Biophys       Date:  2011-11-23       Impact factor: 4.778

8.  Expression, Functional Characterization, and Solid-State NMR Investigation of the G Protein-Coupled GHS Receptor in Bilayer Membranes.

Authors:  Stefanie Schrottke; Anette Kaiser; Gerrit Vortmeier; Sylvia Els-Heindl; Dennis Worm; Mathias Bosse; Peter Schmidt; Holger A Scheidt; Annette G Beck-Sickinger; Daniel Huster
Journal:  Sci Rep       Date:  2017-04-07       Impact factor: 4.379

Review 9.  Binding kinetics of ligands acting at GPCRs.

Authors:  David A Sykes; Leigh A Stoddart; Laura E Kilpatrick; Stephen J Hill
Journal:  Mol Cell Endocrinol       Date:  2019-02-08       Impact factor: 4.102

10.  Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors.

Authors:  David A Sykes; Holly Moore; Lisa Stott; Nicholas Holliday; Jonathan A Javitch; J Robert Lane; Steven J Charlton
Journal:  Nat Commun       Date:  2017-10-02       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.